Filing Details
- Accession Number:
- 0000899866-13-000132
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-16 16:48:09
- Reporting Period:
- 2013-07-12
- Filing Date:
- 2013-07-16
- Accepted Time:
- 2013-07-16 16:48:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
899866 | Alexion Pharmaceuticals Inc | ALXN | Pharmaceutical Preparations (2834) | 133648318 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1337845 | Vikas Sinha | C/O Alexion Pharmacueticals, Inc. 352 Knotter Drive Cheshire CT 06410 | Evp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $.0001 Per Share | Acquisiton | 2013-07-12 | 37,496 | $11.92 | 350,151 | No | 4 | M | Direct | |
Common Stock, Par Value $.0001 Per Share | Acquisiton | 2013-07-12 | 12,504 | $17.65 | 362,655 | No | 4 | M | Direct | |
Common Stock, Par Value $.0001 Per Share | Disposition | 2013-07-12 | 50,000 | $120.00 | 312,655 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, Par Value $.0001 Per Share | Option to Purchase Common Stock | Disposition | 2013-07-12 | 37,496 | $11.92 | 37,496 | $11.92 |
Common Stock, Par Value $.0001 Per Share | Option to Purchase Common Stock | Disposition | 2013-07-12 | 12,504 | $17.65 | 12,504 | $17.65 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2007-11-11 | 2017-07-11 | No | 4 | M | Direct |
101,832 | 2008-04-09 | 2018-01-09 | No | 4 | M | Direct |
Footnotes
- The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.